Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd (TATVA) last traded at ₹1,587, a market capitalisation of ₹3,712 crore, on a P/E of 70.9. Over the past 52 weeks the stock has ranged between ₹976 and ₹1,839. Tatva Chintan Pharma Chem Ltd last reported results for the quarter ended Jun 2026, with sales of ₹167 crore and net profit of ₹16 crore. Figures are as of 25 Aug 2026 and are not real time.
Tatva Chintan Pharma Chem Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Tatva Chintan Pharma Chem Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹167 cr, up 42.7% from ₹117 cr a year earlier. Net profit was ₹16 cr, up 128.6% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 83 | 86 | 108 | 117 | 124 | 131 | 134 | 167 |
| Expenses | 78 | 79 | 99 | 100 | 101 | 106 | 106 | 135 |
| Operating profit | 6 | 7 | 9 | 17 | 22 | 25 | 28 | 32 |
| OPM % | 7% | 8% | 8% | 15% | 18% | 19% | 21% | 19% |
| Other income | 0 | 0 | 1 | 1 | 1 | 2 | -0 | 1 |
| Interest | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 |
| Depreciation | 7 | 7 | 7 | 9 | 9 | 9 | 10 | 11 |
| Profit before tax | -1 | -0 | 2 | 9 | 14 | 18 | 17 | 21 |
| Tax % | -34% | -165% | 49% | 27% | 27% | 14% | 38% | 24% |
| Net profit | -1 | 0 | 1 | 7 | 10 | 15 | 10 | 16 |
| EPS (₹) | -0.28 | 0.06 | 0.44 | 2.84 | 4.24 | 6.49 | 4.41 | 6.83 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Tatva Chintan Pharma Chem Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 300 | 434 | 424 | 394 | 383 | 506 | 556 |
| Operating profit | 67 | 109 | 61 | 69 | 35 | 93 | 108 |
| OPM % | 22% | 25% | 14% | 17% | 9% | 18% | 19% |
| Net profit | 52 | 96 | 45 | 30 | 6 | 42 | 51 |
| EPS (₹) | 26.02 | 43.25 | 20.52 | 12.97 | 2.44 | 17.98 | 21.97 |
TTM is the trailing twelve months to the most recent quarter.
Tatva Chintan Pharma Chem Ltd growth and returns
- 10 Years
- %
- 5 Years
- 11%
- 3 Years
- 6%
- TTM
- 41%
- 10 Years
- %
- 5 Years
- -4%
- 3 Years
- -5%
- TTM
- 632%
- 10 Years
- %
- 5 Years
- -6%
- 3 Years
- -3%
- 1 Year
- 49%
- 10 Years
- %
- 5 Years
- 8%
- 3 Years
- 4%
- Last Year
- 6%
Tatva Chintan Pharma Chem Ltd shareholding pattern
Promoters held 72.02% at Jun 2026, broadly unchanged since Jun 2025. FIIs 3.93% and DIIs 3.11%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% |
| FIIs | 3.33% | 3.36% | 3.30% | 3.26% | 3.40% | 4.17% | 3.81% | 3.93% |
| DIIs | 6.83% | 6.34% | 5.46% | 5.11% | 3.87% | 3.32% | 2.99% | 3.11% |
| Public | 17.81% | 18.27% | 19.21% | 19.60% | 20.72% | 20.49% | 21.16% | 20.94% |
| No. of shareholders | 79,623 | 79,009 | 78,393 | 76,792 | 73,331 | 68,657 | 66,842 | 64,921 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Tatva Chintan Pharma Chem Ltd corporate filings
- Resignation of a Senior Management Personnel of the Company.Company Updatelow impact
Cruxal's analysis: Tatva Chintan Pharma Chem Limited has formally disclosed the resignation of Mr. Ajay…
Read the full analysis - Newspaper Advertisement - Disclosure under Regulation 30 and 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. ....Company Updatelow impact
Cruxal's analysis: Tatva Chintan Pharma Chem Ltd has published a mandatory newspaper advertisement in…
Read the full analysis - Communication to Shareholders - Final Dividend for FY 2025-26 - Intimation on Tax Deduction at source (TDS) / withholding tax on DividendCompany Updatelow impact
Cruxal's analysis: Tatva Chintan Pharma Chem Limited has issued a formal communication to shareholders…
Read the full analysis - Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Company Updatelow impact
Cruxal's analysis: Tatva Chintan Pharma Chem Ltd has announced an upcoming meeting with analysts and…
Read the full analysis - Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Company Updatelow impact
Cruxal's analysis: Tatva Chintan Pharma Chem Ltd has issued an intimation regarding a scheduled meeting with…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Tatva Chintan Pharma Chem Ltd
Cruxal reads every Tatva Chintan Pharma Chem Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.